Proceedings of the Royal Society of Medicine 36 Dr. W. N. Goldsmith: The majority of cases published in recent years have been nonulcerating. Referring to the original case of mine to which Dr. Klaber has alluded, I saw this case six years later and have been intending to publish it. She developed a number of nodules on the thigh which corresponded to Oppenheim's description of the primary lesion. The patient had a very striking family history of tuberculosis, and she herself had had erythema nodosum in the affected leg. While under observation on the second occasion, she was subjected to a Mantoux test which caused a focal reaction around all the lesions, so that at that time I felt rather strongly suspicious that tuberculosis must have something to do with the skin condition. Altogether one wonders whether the primary change is the necrobiosis or the cellular infiltrate. In granuloma annulare, where there is also a peculiar necrosis, one feels nevertheless that the condition is primarily a granuloma and not primarily a necrosis. In another case of mine there was no tuberculosis, but there was severe vascular disease and diabetes; she had, among others, a lesion on the forearm, which is raTe. Dr. Freudenthal excised a very recent and small nodule, only about 0-5 cm. broad, and this showed areas of cellular infiltrate, and hardly a trace of necrosis.
The President: You mean areas of cellular infiltration? Dr. Goldsmith: Yes, cellular infiltration. The point is whether the cellular infiltration is a reaction to the necrobiosis or is itself the first change.
The President: What about the high blood uric acid? Did you come across any other case with that peculiarity? Dr. Semon: No, this is my first case of necrobiosis, I have looked up the literature and have not found any reference to blood uric acid estimations in this connexion.
Dr. Louis Forman: This patient had his fasting blood uric acid and cholesterol estimated in 1941 at Guy's. In 1941 the uric acid was 4-2 milligrams per 100 c.c., i.e. at the top limit of normal, and the serum cholesterol was 168 milligrams per 100 c.c. Unfortunatelr the material could not be stained for fat because we could not fix the section in alcohoI and I think the biopsy took rather a long time to heal. Man aged 61. He has been in the silver trade most of his life, apparently in that part concerned with the manufacture of pilver nitrate crystals. He began to develop the pigmentation about ten years ago. He is a healthy-looking man. There is a grey to black pigmentation extending over his forehead, the upper part of his face, on the backs of his hands, and forearms. The caruncles at the inner canthi of his eyes are quite black, and the conjunctivae apparently stippled with black. On the upper V portion of his chest are discrete greyish-black macular areas which are also present on the back. The patient told me that his hair occasionally goes bright yellow and seems to fall out, and at times his underwear is blackened. He very closely resembles the coloured illustration published by Harker and Hunter (Harker, J. M., and Hunter, D., Brit. J. Derm., 1935, 47, 441) , and I think he may be regarded as a very typical example of occupational argyria. It is hoped to investigate this case more fully.
The President: Is argyria subject to compensation on cosmetic grounds? Dr. H. C. Semon: In my experience hitherto the point has not arisen, and I, hope it will not. It certainly does not conform with the legal definition of dermatitis, and it does not interfere with the man carrying on his work. Argyria (medicamentosa) used to be fairly common at one time When silver nitrate was used for bladder washouts. In America some years ago there was a good deal of trouble on this score from proprietary preparations used for nasal catarrh. P.S.-Stillians, W. W., and Lawless, T. K. (J. Amer. med. Ass., 1929, 92, 20) , have claimed successful bleaching of the pigment by local injections of a mixture of 1% pot. ferrocyanide with 6% sodium thiosulphate.
The President: This man is not so black as the illustration of Hunter's case.
Dr. Louis Forman: I am interested in the appearance of skin in argyria under darkground illumination. In the case I showed at the British Association of Dermatology and Syphilis Meeting in June 1940, the patient had had a congenital fissured tongue with benign transitory plaques, and had used silver nitrate paint for five years. Her skin had become heavily pigmented. Sections demonstrated melanin in the epidermal cells and in cutis, but dark-ground illumination of slides stained by routine methods did not show refractile granules.
Hill and Montgomery (Arch. Derm. Syph., Chicago, 1941, 44, 588-599) repeating Habermann's work, give good illustrations of skin sections of cases of argyria examined under dark-ground illumination. It is best to carry out this examination using sections lightly stained with methylene blue. "With dark-ground illumination under low power, silver shows as yellowish white lines. Higher magnification reveals brilliantly refractile white granules".
The President: There is a paper by Firth, D., and Harrison, G. A. (Brit. J. Derm., 1924, 36, 105) , in which they figured sections showing the location of the silver in the epidermis.
Dr. W. Griffith: Silver nitrate pills were once a common remedy for epilepsy and often gave rise to this condition.
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Lieut.-Colonel F. F. Hellier: In one case I saw in which gold injections were given, the skin after exposure to light acted rather like a photographic plate. The patient developed a purple colour. Fortunately in this patient it was not persistent and cleared up. Possibly a somewhat similar action may occur in argyria.
Dr. Robert Klaber: I have seen cases of "traumatic argyria" in a small factory which uses silver fulminate in preference to fulminate of mercury for the strip inside the Christmas crackers which produces the "bang". However these cases have been less numerous than those affected by dermatitis. Mrs. R. R., a middle-aged woman, living at Leura, New South Wales (elevation nearly 3,000 ft.). Present condition has been developing for three years. Now practically the whole of the face and neck (except at back) are involved. The hands and forearms are not affected. The active edges everywhere are red, prominent and almost verrucose. The follicles are prominent in the active areas, I)ut absent altogether in the scarred patches, which are dead white. The condition extends down the front and sides of the neck, but the back of the neck, where the skin is protected by the hair, is quite clear. The V area in the region of the manubrium sterni is involved. There does not seem to be any doubt that the condition is one of lupus ervthematosus, but it is unusual in type. The patient's home was in the mountains, where the sun is verv bright even in winter, and, in addition, the winter is very cold with frosts daily and snow frequently. Distribution suggests provocative action by sunlight. The hands are not affected because the patient was accustomed to wear gloves almost alwavs when out in the open. No focus of infection or evidence of tuberculosis could be discovered, although Dr. A. Mlacintosh made a very extensive search for any such condition, and, apart from the lupus erythematosus, the patient seemed to be very healthy. (The Honorary Secretary read the case reports. Coloured photographs and a histological section were shown.) Dr. G. B. Dowling: I recall the case of an elderly woman who had bright red areas of subacute lupus erythematosus on the feet and hands as well as on the face and neck. Pituitrin was tried for its blanching effect, a daily dose of 1 c.c. The effect appeared to be remarkable, the condition settling down in about three weeks. I have found pituitrin occasionally useful in other erythematous conditions, such as the acute exudative phase of psoriasis, and in an acute violently red seborrhceic eczema *f the scalp and face.
The President: Does the blanching occur at once? Dr. Dowling: Yes, very soon The President: Perhaps this will provide an explanation of the relief of pain in herpes zoster with pituitrin.
Dr. Freudenthal: The section confirms Dr. Molesworth's diagnosis of lupus erythematosus.
Dr. Robert Klaber: I have certainly seen pituitrin prove effective in rosacea. With regard to other treatment for lupus erythematosus, the use of mapharside has been recommended in America. I have only used it recently in one long-standing case, in which there was no response to bismuth or gold injections. After a few injections, each of 0-04 g., there has been some definite improvement.
Dr. Louis Forman: Superficial erythematous lupus erythematosus is the type usually selected for treatment with sulphonamide. I believe these patients readily become sensitive to sulphonamides, and the associated sulphonamide erythema is frequently more severe around the lupus erythematosus areas, or a flare-up around the lupus erythematosus areas may be the only cutaneous reaction. When this subsides, the lupus erythematosus may have improved. This sequence may be no more than a response to a non-specific reaction.
One must be prepared for frequent cutaneous reactions associated with fever. One case which particularly impressed me was that of a young woman with a relapse of superficial lupus erythematosus. Some months previously she had been given sulphonamide with some improvement, but she said that she felt ill while taking the drug. I took the precaution of giving half a tablet, i.e. i g. only but within half an hour, she complained that she felt ill, her skin became pale, her pulse was imperceptible, and she remained in this severely collapsed condition over night, in spite of resuscitation procedures. Dr. A. N. P. Milner: A case of lupus erythematosus came to me which had failed to respond to gold, bismuth and other treatments. I gave her an intracutaneous injection of moogrol into one lesion in the lateral frontal area close to the left orbit. Only 0-3 c.c. was given. Unfortunately a small amount leaked into the subcutaneous tissue. There was a severe reaction with erythema and considerable cedema which extended to both eye-lids. This settled down with sedative treatment and the lesion healed completely without scarring. Subsequently other lesions were treated more accurately with intracutaneous injections of moogrol, with slight reaction but no healing. I do not consider one is justified in view of this reaction, to give moogrol subcutaneously into the lesions.
